中国社区医师Issue(4)：42-43,2.DOI:10.3969/j.issn.1007-614x.2016.4.24
拉米夫定联合阿德福韦酯治疗HBeAg阳性失代偿期乙肝肝硬化的临床效果
Clinical effect experience of lamivudine combined with adefovir dipivoxil in the treatment of patients with hepatitis B cirrhosis and decompensated HBeAg positive
摘要
Abstract
Objective:To explore the clinical curative effect of lamivudine combined with adefovir dipivoxil in the treatment of patients with hepatitis B cirrhosis and decompensated HBeAg positive.Methods:50 cases of patients with hepatitis B cirrhosis and decompensated HBeAg positive were divided into two groups.The control group was given adefovir dipivoxil after lamivudine,and the research group was given lamivudine combined with adefovir dipivoxil as the initial treatment.The clinical curative effect of two groups was compared.Results:The HBeAg seroconversion rate,Child-Push score,HBV-DNA of the research group were better than those of the control group(P<0.05).Conclusion:Lamivudine combined with adefovir dipivoxil as the initial treatment for patients with hepatitis B cirrhosis and decompensated HBeAg positive had significant clinical curative effect.关键词
HBeAg阳性失代偿期/阿德福韦酯/拉米夫定/乙肝肝硬化Key words
Decompensated HBeAg positive/Adefovir dipivoxil/Lamivudine/Hepatitis B cirrhosis引用本文复制引用
耿红芳..拉米夫定联合阿德福韦酯治疗HBeAg阳性失代偿期乙肝肝硬化的临床效果[J].中国社区医师,2016,(4):42-43,2.
